Medline Procedure Kits Recall
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Medline Industries, LP is recalling 318 medical procedure convenience kits containing recalled Bupivacaine Hydrochloride due to potential drug ineffectiveness.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on August 12, 2026 and geographically references United States. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.
What Happened
Medline Industries, LP initiated a recall of medical procedure convenience kits because they contain ICU Medical, Inc. pain management kits with Bupivacaine Hydrochloride in Dextrose Injection, USP. The kits were recalled due to quality issues that could result in drug ineffectiveness. This is a Class I recall.
Which Products Are Affected
The recall affects 318 kits distributed in Missouri, Colorado, and Illinois. Affected products include:
- TOTAL KNEE-LF, Medline kit SKU CDSOPT590T, Kit Lot Number 24GDA740
- TOTAL KNEE-LF, Medline kit SKU CDSOPT590U, Kit Lot Numbers 26EDA279, 26BDB734, 26ADA474, 25LDA001, 25KDB325, 25GDB517, 25FDB017, 25DDA155, 24LDA248
- TOTAL KNEE CDS, Medline kit SKU CDS983930J, Kit Lot Number 25KBL209
- HIP CDS-LF, Medline kit SKU CDS984556L, Kit Lot Numbers 24JDC180, 24HDA321
- HIP CDS-LF, Medline kit SKU CDS984556M, Kit Lot Number 25ADB327
- TOTAL KNEE PACK, Medline kit SKU DYNJ905162Q, Kit Lot Numbers 26CBD346, 25KBU219
Specific UDI/DI and case/each identifiers are listed in the recall notice.
What You Should Do
Consumers should verify if they possess any of the affected kits with the listed SKUs and lot numbers and follow instructions from the recalling firm regarding the contained recalled drug products.
Why This Matters
The recall involves Class I devices distributed in multiple states, with the potential for the included medication to be ineffective.
Source
FDA recall number Z-2765-2026, report date 20260729.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,496 characters here).
Similar severity timing
Same severity (high) notices issued closest in time to August 12, 2026.
Frequently Asked Questions
Common questions about this FDA recall.